Skolkovo’s startups to showcase at GITEX in Dubai5396
Open Innovations 2016: new location, new format2549
ExoAtlet rehabilitation exoskeletons tested among multiple sclerosis patients885
Speakers from world’s leading companies to share their wisdom at Open Innovations forum589
Inventors get crash course in protecting their IP at annual Patenting School517
Russia, France celebrate 50 years of science cooperation with biotech conference at Skolkovo447
First-hand experience: former resident startupper appointed science director of biomed cluster409
Skolkovo startup to create map of Moscow heat leaks344
Skolkovo startup presents prototype of groundbreaking express stroke test283
Skolkovo’s startups to showcase at GITEX in Dubai0
Inventors get crash course in protecting their IP at annual Patenting School0
ExoAtlet rehabilitation exoskeletons tested among multiple sclerosis patients0
Russia, France celebrate 50 years of science cooperation with biotech conference at Skolkovo0
First-hand experience: former resident startupper appointed science director of biomed cluster0
Open Innovations 2016: new location, new format0
Speakers from world’s leading companies to share their wisdom at Open Innovations forum0
Skolkovo startup presents prototype of groundbreaking express stroke test0
Skolkovo startup to create map of Moscow heat leaks0
Skolkovo biomed cluster resident 3D Bioprinting Solutions has announced the successful printing of a mouse’s thyroid gland.
3D Bioprinting Solutions unveiled Russia's first bioprinter in October. Photo: 3D Bioprinting Solutions
If confirmed, it would reportedly be the world’s first synthetic construction of a complete, transplantable living organ.
“This is undoubtedly a breakthrough in the world of regenerative medicine,” said the bioprinter’s developer Vladimir Mironov. “We have successfully demonstrated the possibilities of Russia’s first bioprinter, and we’re continuing our validation work, systematically testing and optimizing our technology for 3D organ bioprinting,” he added.
The coming weeks will see Mironov’s team attempt to transplant the organ – a matter of millimeters thick - into a mouse suffering from hyperthyroidism, the results of which will be announced at the International Bioprinting Congress in Singapore in June.
The company selected the mouse’s thyroid gland because it is relatively small and simple in design, the lab said. In transplantation, the chance of rejection is minimized by the fact that the mouse’s own stem cells were used as the foundations for the organ, the lab said.
A proud website statement simply read: “The 3D Biprinting Solutions laboratory has successfully conducted the bioprinting of an organ construct of the thyroid gland of a mouse.”
“As was promised last fall, the lab’s scientists finished their work on time – by March 15,” the statement said.
A bioprinter is a machine that fabricates living cells, a technology that could revolutionize modern medicine by providing everything from skin grafts to replacement organs.
The firm 3D Bioprinting Solutions unveiled its 3D bioprinter to the public at the Open Innovations forum in the Russian capital October 14-16.
The bioprinter works by distributing so-called tissue spheroids, or bio-ink, in successive layers in a kind of scaffold structure made of hydrogel. The gel is washed away, leaving behind three-dimensional tissue that matches a computer design down to the individual cell.
Commenting on what Mironov’s achievement means for science, Gelena Livshits, a project manager for Skolkovo’s biomed cluster, said printing an entire organ, not simply a strand of tissue as competitors in the West do, would be a “genuine sensation.”